The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial...
Date First Received: August 16, 2007
Last Updated: June 5, 2008
Verified by: Allergan, June 2008
Clinical Trial Phase: Phase 3 | Start Date: December 2007
Overall Status: Recruiting
Estimated Enrollment: 450
Brief Summary
Condition Keyword(s):
Intervention(s):
The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Study Primary Completion Date: June 2009
Intervention(s) in this Clinical Trial
- Drug: gatifloxacin 0.5% eye drops
- Day 1= 1 drop study med every 2 hrs up to 8 times total; Day 2-5= 1 drop twice daily placebo
- Drug: placebo eye drops
- Day 1= 1 drop study med every 2 hrs up to 8 times total; Day 2-5= 1 drop twice daily
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: 1
- Placebo Comparator: 2
Outcome Measures for this Clinical Trial
Primary Measures
- Proportion of patients with clearing of conjunctival hyperemia and conjunctival discharge
- Time Frame: Day 6
Safety Issue?: No
- Time Frame: Day 6
Secondary Measures
- Microbiological cure
- Time Frame: Day 6
Safety Issue?: No
- Time Frame: Day 6
- Clinical improvement of ocular signs
- Time Frame: Day 6
Safety Issue?: No
- Time Frame: Day 6
- Clinical improvement of ocular symptoms
- Time Frame: Day 6
Safety Issue?: No
- Time Frame: Day 6
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Clinically diagnosed with bacterial conjunctivitis
Exclusion Criteria:
- Signs and/or symptoms of conjunctivitis for more than 96 hours
- Signs and/or symptoms suggestive of fungal, viral, or allergic conjunctivitis
- Clinical diagnosis of chlamydia in either eye
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 1 Year
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Allergan
Overall Clinical Trial Officials and Contacts
Overall Contact: Allergan Inc clinicaltrials@allergan.com
Additional Information
Information obtained from ClinicalTrials.gov on September 05, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00518089
Study ID Number: 198782-005
ClinicalTrials.gov Identifier: NCT00518089
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.